This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chen, M. Articles by Beck, W. T. Search for Related Content PubMed PubMed Citation Articles by Chen, M. Articles by Beck, W. T.

Differences in Inhibition of Chromosome Separation and G₂ Arrest by DNA Topoisomerase II Inhibitors Merbarone and VM-26¹

Department of Molecular Pharmacology, St. Jude Children's Research Hospital, Memphis 38101 [M. C., W. T. B.] and Department of Pharmacology, College of Medicine, University of Tennessee, Memphis, Tennessee 38163 [M. C., W. T. B.]

Merbarone, a novel DNA topoisomerase II (topo II) inhibitor, differs from teniposide (VM-26) in that it inhibits topo II activities without stabilizing topo II-DNA covalent complexes. Thus, while the cellular effects of VM-26 are the consequences of inhibition of topo II catalytic activities and generation of topo II-mediated DNA damage, those of merbarone may be due to inactivation of topo II catalytic function. To address the issues of mechanisms of cell cycle effects and pharmacological actions of these two topo II inhibitors in mammalian cells, we used synchronized cultures of HeLa cells to study the effects of these drugs on cell cycle processes where topo II is essential (e.g., chromosome separation) or possibly involved (e.g., G₂ arrest, DNA replication). We found that both drugs inhibited chromosome separation and cell division without preventing cells from exiting mitosis. Both drugs caused S-phase retardation, G₂ arrest, and phase-specific cytotoxicity in that they are more toxic to S, M, and G₂ cells than G₀/G₁ cells. However, merbarone produced the above effects in convergent dosages that were within one to five times its 90% inhibitory cytotoxic concentration, whereas the concentrations of VM-26 to cause quantitatively similar effects were quite divergent. VM-26 is 50–100-fold more efficient in causing G₂ arrest than in inhibiting chromosome separation. Furthermore, at concentrations showing similar levels of S-phase suppression, VM-26 caused significant DNA breaks, while merbarone had no such effect. Our data suggest that the effects of merbarone and VM-26 during mitosis are most likely due to inhibition of topo II function. We conclude that while G₂ arrest by VM-26 is related to topo II-mediated DNA damage and its sequelae, G₂ arrest by merbarone likely results from different mechanisms.

¹ This work was supported in part by Research Grants CA-40570 and CA-30103, by Cancer Center Support (CORE) Grant CA-21765 from the National Cancer Institute, Department of Health and Human Services (Bethesda, MD), and in part by American Lebanese Syrian Associated Charities (Danny Thomas, Founder).

² To whom requests for reprints should be addressed, at Department of Molecular Pharmacology, St. Jude Children's Research Hospital, 332 North Lauderdale, Memphis, TN 38101.

Received 10/ 4/94. Accepted 2/ 2/95.

This article has been cited by other articles:

				F. Cortes and N. Pastor Induction of endoreduplication by topoisomerase II catalytic inhibitors Mutagenesis, March 1, 2003; 18(2): 105 - 112. [Abstract] [Full Text] [PDF]

				L. H. Jensen, K. C. Nitiss, A. Rose, J. Dong, J. Zhou, T. Hu, N. Osheroff, P. B. Jensen, M. Sehested, and J. L. Nitiss A Novel Mechanism of Cell Killing by Anti-topoisomerase II Bisdioxopiperazines J. Biol. Chem., January 21, 2000; 275(3): 2137 - 2146. [Abstract] [Full Text] [PDF]

				K. Patteson, P. Wang, and L. F. Povirk Enhanced Amsacrine-induced Mutagenesis in Plateau-Phase Chinese Hamster Ovary Cells, with Targeting of +1 Frameshifts to Free 3' Ends of Topoisomerase II Cleavable Complexes Cancer Res., August 1, 1999; 59(15): 3682 - 3688. [Abstract] [Full Text] [PDF]

				T. Khélifa and W. T. Beck Merbarone, a Catalytic Inhibitor of DNA Topoisomerase II, Induces Apoptosis in CEM Cells through Activation of ICE/CED-3-like Protease Mol. Pharmacol., March 1, 1999; 55(3): 548 - 556. [Abstract] [Full Text]

				P. Grue, A. Grasser, M. Sehested, P. B. Jensen, A. Uhse, T. Straub, W. Ness, and F. Boege Essential Mitotic Functions of DNA Topoisomerase IIalpha Are Not Adopted by Topoisomerase IIbeta in Human H69 Cells J. Biol. Chem., December 11, 1998; 273(50): 33660 - 33666. [Abstract] [Full Text] [PDF]

				J. M. Fortune and N. Osheroff Merbarone Inhibits the Catalytic Activity of Human Topoisomerase IIalpha by Blocking DNA Cleavage J. Biol. Chem., July 10, 1998; 273(28): 17643 - 17650. [Abstract] [Full Text] [PDF]

				T. R. Hammonds and A. Maxwell The DNA Dependence of the ATPase Activity of Human DNA Topoisomerase IIalpha J. Biol. Chem., December 19, 1997; 272(51): 32696 - 32703. [Abstract] [Full Text] [PDF]

				M. S. Orr, N. C. Watson, S. Sundaram, J. K. Randolph, P. T. Jain, and D. A. Gewirtz Ionizing Radiation and Teniposide Increase p21waf1/cip1 and Promote Rb Dephosphorylation but Fail to Suppress E2F Activity in MCF-7 Breast Tumor Cells Mol. Pharmacol., September 1, 1997; 52(3): 373 - 379. [Abstract] [Full Text]